Interestingly, Tai et al. demonstrated that the nitric oxide donor, S-nitroso-N-acetylpenicillamine, acted principally through posttranslational modification of p53, phosphorylated NDRG1, and MGMT protein stability in TMZ resistant GBM cells [75]. The gene discussed is TP53; the disease is glioblastoma.